Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Sumitomo Dainippon Flip-Plops on Sales Force Cutback as It Ramps Up Diabetes Push
After a DPP-4 copromotion pact inked with Novartis Pharma, Sumitomo Dainippon Pharma is making a U-turn with its previous plan to pare down its sales force and is now set to even hire more contract reps in a bid to…
To read the full story
Related Article
- Sumitomo Dainippon to Solely Promote Novartis Diabetes Meds from January
November 20, 2019
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





